Achieve Life Sciences' cytisine shows encouraging effect in smoking cessation study; shares up 54% [Seeking Alpha]
Achieve Life Sciences, Inc. - Common Shares (ACHV)
Last achieve life sciences, inc. - common shares earnings: 3/13 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.achievelifesciences.com
Company Research
Source: Seeking Alpha
Achieve Life Sciences' cytisine shows encouraging effect in smoking cessation study; shares up 54%Thinly traded nano cap Achieve Life Sciences (NASDAQ:ACHV) is up54% premarket on increased volume in response to its announcement ofpositive results from a Phase 1/2 clinical trial evaluating cytisine in 24 healthy volunteer smokers over a 25-day treatment period.Pharmacokinetic data showed increases in plasma concentration between the standard and higher doses of cytisine with no evidence of drug accumulation. 58% (n=14/24) of smokers achieved abstinence on day 26, 50% (n=6/12) in the 1.5 mg arm and 67% (n=8/12) in the 3.0 mg arm. Those who were unable to quit entirely, were smoking considerably less cigarettes per day at the end of treatment.On the safety front, most adverse events (AEs) were mild and transitory. The most frequent AE was transient headache.Cytisine is a plant-based alkaloid with a strong affinity to the nicotinic acetylcholine receptor.Phase 3 development will start mid
Show less
Read more
Impact Snapshot
Event Time:
ACHV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACHV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACHV alerts
High impacting Achieve Life Sciences, Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
ACHV
News
- Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual MeetingGlobeNewswire
- Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024GlobeNewswire
- Achieve Life Sciences Announces Participation at Upcoming Investor ConferencesGlobeNewswire
- Achieve Life Sciences, Inc. (NASDAQ: ACHV) had its price target lowered by analysts at Lake Street Capital from $19.00 to $11.00. They now have a "buy" rating on the stock.MarketBeat
- Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement [Yahoo! Finance]Yahoo! Finance
ACHV
Earnings
- 11/9/23 - In-Line
ACHV
Sec Filings
- 3/11/24 - Form SC
- 3/6/24 - Form 4
- 3/6/24 - Form 4
- ACHV's page on the SEC website